Keyphrases
Apoptosis
100%
Interleukin-4 (IL-4)
100%
Porcine Endothelial Cells
100%
Porcine
40%
JAK3
26%
Phosphorylation
20%
Tumor Necrosis Factor-α
20%
Galactosyltransferase
13%
Vascular Rejection
13%
Protein Expression
6%
Virus
6%
Endothelial Cells
6%
In Cancer
6%
Deleterious Effects
6%
Small Interfering RNA (siRNA)
6%
Organ Transplantation
6%
Xenograft
6%
B-cell Lymphoma 2 (Bcl-2)
6%
Protective Proteins
6%
Therapeutic Agents
6%
Heat Shock Protein 70 (HSP70)
6%
Signaling Molecules
6%
Recombinant Adenovirus
6%
Pharmacological Inhibitors
6%
Vascular Endothelium
6%
Cellular Level
6%
Cancer Pathogenesis
6%
Xenotransplantation
6%
Inducer
6%
Primary Culture
6%
Signal Process
6%
Cycloheximide
6%
Cell-derived
6%
Apoptosis Inhibition
6%
Flow Cytometry
6%
Extracellular Signal-regulated Kinase 1/2
6%
Bcl-xL
6%
Immunoblotting
6%
Pleiotropic Effects
6%
Tissue Injury
6%
Tissue Homeostasis
6%
AKT Pathway
6%
Interleukin-13 (IL-13)
6%
Induced Resistance
6%
Endothelial Cell Activation
6%
Inhibitor of Apoptosis Proteins
6%
Tissue Development
6%
Effective Rate of Protection
6%
MTOR Complex 2 (mTORC2)
6%
Neutral Red Uptake
6%
Immortalized Cell
6%
Hemoxygenase-1
6%
Biochemistry, Genetics and Molecular Biology
Interleukin 4
100%
Programmed Cell Death
100%
STAT6
26%
Tumor Necrosis Factor
20%
Wild Type
13%
Galactosyltransferase
13%
Small Interfering RNA
6%
Pleiotropy
6%
Signaling Protein
6%
Inhibitor of Apoptosis
6%
Primary Culture
6%
Protein Kinase B
6%
Adenoviridae
6%
Homeostasis
6%
Protein Expression
6%
Cell Activation
6%
down Regulation
6%
Cell Level
6%
Extracellular Signal-Regulated Kinases
6%
Bcl-xL
6%
Bcl-2
6%
Cycloheximide
6%
Mammalian Target of Rapamycin Complex 2
6%
Heat Shock Protein
6%
Interleukin 13
6%
Flow Cytometry
6%
Immunoblotting
6%
Immunology and Microbiology
Interleukin 4
100%
Programmed Cell Death
100%
STAT6
26%
Tumor Necrosis Factor
20%
Acute Vascular Rejection
13%
Wild Type
13%
Xenograft
6%
Virus
6%
Organ Transplantation
6%
Western Blot
6%
Heat Shock
6%
Protein Expression
6%
Adenoviridae
6%
Homeostasis
6%
down Regulation
6%
Cell Activation
6%
Primary Culture
6%
Vascular Endothelium
6%
Bcl-2
6%
Cell Level
6%
Interleukin 13
6%
Mammalian Target of Rapamycin Complex 2
6%
Xenotransplantation
6%
Pleiotropy
6%
Pharmacology, Toxicology and Pharmaceutical Science
Interleukin 4
100%
STAT6 Protein
26%
Tumor Necrosis Factor
20%
Acute Vascular Rejection
13%
Galactosyltransferase
13%
Flow Cytometry
6%
Western Blot
6%
Primary Culture
6%
Malignant Neoplasm
6%
Small Interfering RNA
6%
Adenoviridae
6%
Mitogen Activated Protein Kinase 3
6%
Tissue Injury
6%
Baculoviral IAP Repeat Containing Protein 3
6%
Heat Shock Protein 70
6%
Mammalian Target of Rapamycin Complex 2
6%
Cycloheximide
6%
Interleukin 13
6%
Neutral Red
6%
Veterinary Science and Veterinary Medicine
STAT6
100%
Neoplasm
75%
Cancer
25%